PTCT compared with GMED: revenue, margins and what each company keeps, and the suppliers and customers both name

PTCTPTC Therapeutics, Inc.

Mkt capRevenueRevenue

GMEDGlobus Medical Inc

Mkt capRevenueRevenue

Compare

PTCTPTC Therapeutics, Inc.

GMEDGlobus Medical Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PTCT 13

PGENPrecigensupplier

IONSIonis Pharmaceuticalssupplier

NVSNovartis Pharmaceuticalscustomer

—Akcea Therapeuticsunlistedsupplier

9 more · PTCT chain ›

Shared 0

No disclosed counterparties: GMED.

Only GMED 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

PTCTPTC Therapeutics, Inc.

65.64▼−4.83%· post 64.96· delayed

Mkt cap$5.8BRevenue$361MQ2 FY26Revenue$1.7BFY25

GMEDGlobus Medical Inc

81.16▼−6.82%· post 78.50· delayed

After hoursNov 5 '26delayed

Mkt cap$11.7BRevenue$764MQ3 FY26Revenue$2.9BFY25

Compare

After hoursNov 5 '26delayed

PTCTPTC Therapeutics, Inc.

GMEDGlobus Medical Inc

65.64▼−4.83%post 64.96delayed

Price

81.16▼−6.82%post 78.50delayed

$5.8B

Mkt cap

$11.7B

Q2 FY26$361M

Revenue

$764MQ3 FY26

FY25$1.7B

Revenue

$2.9BFY25

PTCT65.64▼−4.83%vsGMED81.16▼−6.82%After hoursNov 5 '26delayed